A Clinical Trial of Ginseng in Diabetes
Completed · Early Phase 1 · Has a placebo group
Conditions studied: Diabetes
In brief
a clinical study of Ginseng its potential affect on diabetes
Key facts
- Study ID
- NCT00781534
- Run by
- Washington University School of Medicine
- People needed
- 19
- Starts
- 2003-09-01
- Expected to finish
- 2008-09-01
- Last updated by the study team
- 2019-09-09
Who can join
Age: 18 and older, up to 65. Sex: any. Healthy volunteers: accepted.
You may qualify if…
- ages 18-65
- healthy, non-diabetic
- healthy, impaired glucose tolerance/mild diabetes (no medications required)
You may not qualify if…
- impaired glucose tolerance (borderline diabetes that requires medications)
- diabetes (requiring medications)
- caffeine sensitivity
- known cardiac, peripheral vascular diseases
- arrhythmias (irregular heart rhythms)
Where it is running
- Washington University School of Medicine — St Louis, Missouri, United States
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.